Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00016198 · ClinicalTrials.gov registry record · Phase 2
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
A Phase 2 study, sponsored by Prologue Research International.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00016198: Completed Phase 2 study, sponsored by Prologue Research International.
NCT00016198 is a Phase 2 study that has completed, run by Prologue Research International. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00016198, a Phase 2 study, has completed, sponsored by Prologue Research International.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combining fluorouracil and leucovorin with or without oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.
Interventions
- DRUG FOLFOX regimen
- DRUG oxaliplatin
- DRUG fluorouracil
- DRUG leucovorin calcium
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-05 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00016198
The ClinicalTrials.gov registry entry for NCT00016198 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Prologue Research International, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which FOLFOX regimen is the first listed.
NCT00016198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00016198 about?
NCT00016198 is a clinical study titled "Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combining fluorouracil and leucovorin with or without oxal...
What is the current status of trial NCT00016198?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00016198?
The interventions under investigation include: FOLFOX regimen (DRUG), oxaliplatin (DRUG), fluorouracil (DRUG), leucovorin calcium (DRUG).
Who is sponsoring clinical trial NCT00016198?
This trial is sponsored by Prologue Research International, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.